Search
for
Sort by
Research 631–660 of 1000+
- Intraovarian vascular enhancement via stromal injection of platelet-derived growth factors: Exploring subsequent oocyte chromosomal status and in vitro fertilization outcomes
- The Treatment of Hyperandrogenism with Oral Contraceptives
- Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: a prospective cross-sectional study
- Studies of the components of an oral contraceptive agent in albino rats. II. Progestogenic component and comparison of effects of the components and the combined agent
- 9 Diagnosis and therapy of hyperandrogenism
- HIRSUTISM IN FEMALES; A CLINICAL STUDY OF ITS ETIOLOGY, COURSE AND TREATMENT
- lncRNA H19 acts as a ceRNA to regulate the expression of CTGF by targeting miR-19b in polycystic ovary syndrome
- Endocrine profile of the VCD-induced perimenopausal model rat
- Current evaluation of amenorrhea
- Treatment of hirsutism with spironolactone
- Regression of Pathologic Changes Induced by the Long-term Administration of Contraceptive Steroids to Rodents
- The Utility of Metformin Therapy in Reproductive-Aged Women with Polycystic Ovary Syndrome (PCOS)
- Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception
- The role of ultrasound and Doppler analysis in the diagnosis of polycystic ovary syndrome
- Postmenopausal hyperandrogenism
- Current concepts in aesthetic endocrinology
- Alopecia and Hirsuties
- Relationship of androgens to female hirsutism and infertility.
- Approach to androgen excess in women: Clinical and biochemical insights
- Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women
- Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
- Baicalin inhibits recruitment of GATA1 to the HSD3B2 promoter and reverses hyperandrogenism of PCOS
- Anti-Müllerian hormone confirms the novel classification of female functional androgenization including polycystic ovary syndrome
- New onset alopecia and hirsutism in a postmenopausal women
- The profile of steroid hormones in human fetal and adult ovaries
- The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration
- Choice of treatment for women with polycystic ovary syndrome
- Female pattern hair loss: Clinical features and potential hormonal factors
- Operative transvaginal hydrolaparoscopy improve ovulation rate after clomiphene failure in polycystic ovary syndrome
- Hyperandrogénie féminine